Ashley Gallagher, MA

Community pharmacy workflows can support medical billing and new clinical services, empowering technicians and freeing pharmacists for patient care.

Non-high-density lipoprotein cholesterol matters in type 2 diabetes care and can be managed with statins, combination therapy, and omega‑3s.

Meta-analysis shows PCV13 followed by PPSV23 boosts pneumococcal immunity in seniors without added adverse effects.

This decision marks a historic milestone as sparsentan becomes the first and only medication specifically approved for this rare and devastating condition.

Community pharmacists guide minor wound care—clean, protect, and monitor—spot infection risks, and refer serious injuries quickly to prevent complications.

Pharmacists can help to choose the right ingredient and avoid drug interactions for OTC relief for gas, motion sickness, nausea, and heartburn.

Tentative FDA nod for generic semaglutide signals more glucagon-like peptide-1 access, easing pharmacy hurdles and curbing risky compounded alternatives.

Meta-analysis shows CGM lowers HbA1c and hypoglycemia in insulin-treated type 2 diabetes, while pharmacists tackle training, costs, and skin issues.

Social determinants of health shape pneumococcal risk, making vaccination especially important for specific populations.

Lunsekimig cuts asthma exacerbations and boosts lung function while improving nasal polyps—an emerging dual-target biologic for respiratory care.

New evidence links poor sleep and diabetes risk to widespread prenatal anxiety, urging pharmacists to support metabolic control and mental health.

An Iowa independent pharmacy runs a cash-pay test‑to‑treat mini clinic, which streamlines workflow and expands patient access fast.

Self-regulating hydrogel speeds diabetic foot ulcer healing, cutting wound area 94% in 4 weeks through smart pH-guided ion release.

Pharmacists face alarming burnout rates, but hobbies—from horses to sports—can help protect mental health and keep patient care safer.

Investigators of the multicenter cohort aim to determine if the 13-valent pneumococcal conjugate vaccine impacted disease activity over a 24-month period.

A growing body of evidence suggests that the choice of glucose-lowering therapy may play a critical role in colorectal cancer prevention.

Ulcers represent one of the most serious and costly complications of diabetes characterized by a high risk of recurrence.

Wounds are defined as disruptions of tissue integrity that can occur in the skin, mucous membranes, or internal organs, often accompanied by pain and infection risks.

Pharmacists spot diabetes risk early, explain heart- and kidney-protecting meds, decode CGM data, and find affordable support.

Orforglipron is the first new molecular entity to be cleared under the FDA Commissioner's National Priority Voucher pilot program.

Timothy Aungst, PharmD, and Ravi Patel, PharmD, MBA, MS, unpack the role of direct-to-patient in the current pharmacy landscape.

The question facing many independents is no longer whether vaccines matter but whether a vaccine program is truly right for their pharmacy.

This study indicates that stopping the medication is noninferior to continuing it indefinitely in terms of preventing death, recurrent heart attacks, or hospitalizations.

This benefit was primarily driven by significant reductions in nonfatal heart attacks and the need for revascularization procedures.

The study demonstrated that providing a combination of produce prescriptions, dietitian coaching, and artificial intelligence-optimized encouragement led to improved cardiovascular outcomes.

The biosimilar is approved for all indications of the reference product, including the treatment of postmenopausal women with osteoporosis at high risk for fracture.

As population-level introduction of pneumococcal conjugate vaccines has led to an increase in invasive disease, the development of higher-valency vaccines has become a primary solution.

Serotype 19F resurges despite PCVs, raising invasive disease risk in older adults; pharmacists track immune evasion, variants, and boost adherence.

The FDA approves removing the age requirement for epinephrine nasal spray (neffy) 1 mg, effectively allowing all children and adults who weigh 33 pounds.

These guidelines serve as a comprehensive guideline that prioritizes earlier intervention through lifestyle optimization and lower treatment targets for those at highest risk.